Multi-layer macromonocyclic polyamines. I. Molecular design and synthesis of component monocyclic precursors

Bulletin of the Chemical Society of Japan

Volumn 73, Issue 3, 2000, Pages 693-704

  Iwata, Masaaki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

POLYAMINE DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CYCLIZATION; HYDROGENATION; MOLECULAR INTERACTION; PRECURSOR; REACTION ANALYSIS; SPECTROMETRY; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 0034022788     PISSN: 00092673     EISSN: None     Source Type: Journal    
DOI: 10.1246/bcsj.73.693     Document Type: Article

References (47)

1. H. G. Bernstein and M. Muller, Prog. Neurobiol., 57, 485 (1999).
2. A. Bouchereau, A. Aziz, F. Larher, and J. Martin Tanguy, Plant Sci., 140, 103 (1999).
3. C. H. Kao, Botan. Bull. Acad. Sinica, 38, 141 (1997).
4. M. K. Chattopadhyay and B. Ghosh, Curr. Sci., 74, 517 (1998).
5. C. J. Bacchi and N. Yarlett, Acta Tropica, 54, 225 (1993).
6. M. Yoshioka, Yakugaku Zasshi - J. Pharm. Soc. Jpn., 117, 700 (1997).
7. Y. Itagaki, H. Naoki, T. Fujitu, M. Hisada, and T. Nakajima, Yakugaku Zasshi - J. Pharm. Soc. Jpn., 117, 715 (1997).
8. R. Balana Fouce, R. M. Reguera, J. C. Cubria, and D. Ordonez, Gen. Pharmacol., 30, 435 (1998).
9. N. Seiler, C. L. Atanassov, and F. Raul, Int. J. Oncol., 13, 993 (1998).
10. C. W. Porter and R. J. Bergeron, Adv. Exper. Med. Biol., 250, 677 (1988).
11. K. Williams, Biochem. J., 325, 289 (1997).
12. K. Williams, Cell. Signal., 9, 1 (1997).
13. T. D. Johnson, Trends Pharmacol. Sci., 17, 22 (1996).
14. R. H. Scott, K. G. Sutton, and A. C. Dolphin, Trends Neurosci., 16, 153 (1993).
15. A. U. Bielinska, J. F. Kukowskalatallo, and J. R. Baker, Biochim. Biophys. Acta - Gene Str. Express., 1353, 180 (1997).
16. M. Frugier, C. Florentz, M. W. Hosseini, J. M. Lehn, and R. Giege, Nucl. Acids Res., 22, 2784 (1994).
17. E. DeClercq, N. Yamamoto, R. Pauwels, M. Baba, D. Schols, H. Nakashima, J. Balzarini, Z. Debyser, B. Murrer, D. Schwartz, D. Thornton, G. Bridger, S. Fricker, G. Henson, M. Abrams, and D. Picker, Proc. Natl. Acad. Sci. U.S.A., 89, 5286 (1992).
18. E. DeClercq, N. Yamamoto, R. Pauwels, J. Balzarini, M. Witvrouw, K. Devreese, Z. Debyser, B. Rosenwirth, P. Peichl, R. Datema, D. Thornton, R. Skerlj, F. Gaul, S. Padmanabhan, G. Bridger, G. Henson, and M. Abrams, Antimicrob. Agents Chemother., 38, 668 (1994).
19. Y. Inoue, T. Kanamori, T. Yoshida, X. Bu, M. Shionoyu, T. Koike, and E. Kimura, Biol. Pharm. Bull., 17, 243 (1994).
20. Y. Inoue, T. Kanamori, M. Sugiyama, T. Yoshida, T. Koike, M. Shionoya, K. Enomoto, K. Suehiro, and E. Kimura, Antiviral Chem. Chemotherapy, 6, 337 (1995).
21. D. Schols, S. Struyf, J. A. Damme, J. A. Este, G. Henson, and E. DeClercq, J. Exp. Med., 186, 1383 (1997).
22. C. Bazzicalupi, A. Bencini, A. Bianchi, C. Giorgi, and B. Valtancoli, Coord. Chem. Rev., 184, 243 (1999).
23. C. Destefano, C. Foti, and O. Giuffre, J. Solution Chem., 25, 155 (1996).
24. R. Hettich and H. J. Schneider, J. Am. Chem. Soc., 119, 5638 (1997).
25. L. Lomozik, A. Gasowska, and L. Bolewski, J. Chem. Soc., Perkin Trans. 2, 1997, 1161.
26. M. Musso, T. Thomas, A. Shirahata, L. H. Sigal, M. W. Vandyke, and T. J. Thomas, Biochem., 36, 1441 (1997).
27. T. Sawada, K. Fukumaru, and H. Sakurai, Chem. Pharm. Bull., 44, 1009 (1996).
28. A. Jyo, Y. Terazono, and H. Egawa,Anal. Sci., 11, 51 (1995).
29. J. C. Hsu, W. H. Chen, and C. Y. Liu, Analyst, 122, 1393 (1997).
30. G. Wu, R. Izatt, M. Bruening, W. Jiang, H. Azab, K. Krakowiak, and J. Bradshaw, J. Inclus. Phenom. Mol. Recogn. Chem., 13, 121 (1992).
31. M. W. Hosseini, J.-M. Lehn, L. Maggiora, K. B. Mertes, and P. Mertes, J. Am. Chem. Soc., 109, 537 (1987).
32. (n-3)/2. For example, when n equals 2, 3, 4, 5, 6, or 7, S becomes 2, 3, 6, 10, 20, or 36, respectively, indicating rapid effect on emergence of acquired-polymorphism by overlapping of cycles in this fashion.
33. M. Iwata and H. Kuzuhara, Bull. Chem. Soc. Jpn., 62, 198 (1989).
34. M. Iwata and H. Kuzuhara, Bull. Chem. Soc. Jpn., 62, 1102 (1989).
35. E. Kimura, Yakugaku Zasshi - J. Pharm. Soc. Jpn., 116, 587 (1996).
36. E. Kimura, Yakugaku Zasshi - J. Pharm. Soc. Jpn., 102, 701 (1982).
37. J. S. Bradshaw, K. E. Krakowiak, and R. M. Izatt, Tetrahedron, 48, 4475 (1992).
38. K. E. Krakowiak, J. S. Bradshaw, and D. J. Zamecka-Krakowiak, Chem. Rev., 89, 929 (1989).
39. G. W. Gokel, D. M. Dishong, R. A. Schultz, and V. J. Gatto, Synthesis, 1982, 997.
40. K. Mochizuki and S. Miyashita, Chem. Lett., 1996, 899.
41. 2-N-. ArMe-protons designate methyl protons attached to aromatic ring. ArHme-protons designate aromatic protons disposed at position ortho to the methyl group. ArHs-protons designate aromatic protons disposed at position ortho to the sulfonyl group.
42. M. Iwata and H. Kuzuhara, Bull. Chem. Soc. Jpn., 55, 2153 (1982).
43. M. Iwata and H. Kuzuhara, Bull. Chem. Soc. Jpn., 59, 1031 (1986).
44. J. E. Richman and T. J. Attkins, J. Am. Chem. Soc., 96, 2268 (1974).
45. M. Iwata, K. Kobayashi, and S. Tsuboyama, Anal. Sci., 12, 819 (1996).
46. S. Gabriel and J. Weiner, Ber. Dtsch. Chem. Ges., 21, 2669 (1888).
47. M. Iwata, K. Kobayashi, and S. Tsuboyama, Anal. Sci., 13, 159 (1997).